Literature DB >> 25917063

MicroRNA-9 promotion of interleukin-6 expression by inhibiting monocyte chemoattractant protein-induced protein 1 expression in interleukin-1β-stimulated human chondrocytes.

Mohammad S Makki1, Abdul Haseeb1, Tariq M Haqqi1.   

Abstract

OBJECTIVE: Enhanced expression of interleukin-6 (IL-6) plays an important role in the pathogenesis of osteoarthritis (OA). Monocyte chemoattractant protein-induced protein 1 (MCPIP-1) is a novel posttranscriptional regulator of IL-6 expression and is targeted by microRNA-9 (miR-9). We investigated the expression of MCPIP-1 in OA cartilage and explored whether targeting of MCPIP-1 by miR-9 contributes to enhanced IL-6 expression in OA.
METHODS: Gene and protein expression in IL-1β-stimulated human OA chondrocytes/cartilage was determined by TaqMan assay and immunoblotting, respectively. Messenger RNA (mRNA) for MCPIP-1 and IL-6 expression at the single-cell level was analyzed using RNAscope. MCPIP-1 protein interaction with IL-6 mRNA was investigated using RNA immunoprecipitation. Transient transfections were used for the small interfering RNA (siRNA)-mediated knockdown and overexpression of MCPIP-1, its RNase-defective mutant miR-9, or antagomir. The role of signaling pathways was evaluated using small-molecule inhibitors. Binding of miR-9 with the "seed sequence" in the 3'-untranslated region of MCPIP-1 mRNA was investigated using a luciferase reporter assay.
RESULTS: MCPIP-1 mRNA expression was low, but expression of miR-9 and IL-6 was high, in damaged OA cartilage. In IL-1β-stimulated OA chondrocytes, the expression of miR-9 and MCPIP-1 was mutually exclusive, and increased expression of miR-9 correlated with reduced MCPIP-1 expression and enhanced IL-6 expression. MCPIP-1 protein directly binds with IL-6 mRNA, and overexpression of wild-type MCPIP-1 destabilized the IL-6 mRNA. MCPIP-1 expression was altered by overexpression or inhibition of miR-9. Transfection with miR-9 mimics inhibited the reporter activity, and mutation of the "seed sequence" abolished the repression of reporter activity.
CONCLUSION: These findings implicate miR-9-mediated suppression of MCPIP-1 in the pathogenesis of OA via up-regulation of IL-6 expression in IL-1β-stimulated human OA chondrocytes.
© 2015, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25917063      PMCID: PMC4519390          DOI: 10.1002/art.39173

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  47 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  Bone mineral density and association of osteoarthritis with fracture risk.

Authors:  M Y Chan; J R Center; J A Eisman; T V Nguyen
Journal:  Osteoarthritis Cartilage       Date:  2014-07-18       Impact factor: 6.576

3.  MicroRNA-602 and microRNA-608 regulate sonic hedgehog expression via target sites in the coding region in human chondrocytes.

Authors:  Nahid Akhtar; Mohammad S Makki; Tariq M Haqqi
Journal:  Arthritis Rheumatol       Date:  2015-02       Impact factor: 10.995

4.  MicroRNA-140 plays dual roles in both cartilage development and homeostasis.

Authors:  Shigeru Miyaki; Tempei Sato; Atsushi Inoue; Shuhei Otsuki; Yoshiaki Ito; Shigetoshi Yokoyama; Yoshio Kato; Fuko Takemoto; Tomoyuki Nakasa; Satoshi Yamashita; Shuji Takada; Martin K Lotz; Hiroe Ueno-Kudo; Hiroshi Asahara
Journal:  Genes Dev       Date:  2010-05-13       Impact factor: 11.361

5.  MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes.

Authors:  Nahid Akhtar; Zafar Rasheed; Sangeetha Ramamurthy; Arivarasu N Anbazhagan; Frank R Voss; Tariq M Haqqi
Journal:  Arthritis Rheum       Date:  2010-05

6.  Modulation of ten-eleven translocation 1 (TET1), Isocitrate Dehydrogenase (IDH) expression, α-Ketoglutarate (α-KG), and DNA hydroxymethylation levels by interleukin-1β in primary human chondrocytes.

Authors:  Abdul Haseeb; Mohammad Shahidul Makki; Tariq M Haqqi
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

7.  Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo.

Authors:  Kazuya Masuda; Barry Ripley; Riko Nishimura; Takashi Mino; Osamu Takeuchi; Go Shioi; Hiroshi Kiyonari; Tadamitsu Kishimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-15       Impact factor: 11.205

8.  The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13.

Authors:  S W Jones; G Watkins; N Le Good; S Roberts; C L Murphy; S M V Brockbank; M R C Needham; S J Read; P Newham
Journal:  Osteoarthritis Cartilage       Date:  2008-10-11       Impact factor: 6.576

9.  Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes.

Authors:  Zafar Rasheed; Nahid Akhtar; Tariq M Haqqi
Journal:  Arthritis Res Ther       Date:  2010-10-18       Impact factor: 5.156

10.  Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma.

Authors:  Hai-Ying Wan; Li-Min Guo; Tao Liu; Min Liu; Xin Li; Hua Tang
Journal:  Mol Cancer       Date:  2010-01-26       Impact factor: 27.401

View more
  35 in total

Review 1.  Regnase-1, a rapid response ribonuclease regulating inflammation and stress responses.

Authors:  Renfang Mao; Riyun Yang; Xia Chen; Edward W Harhaj; Xiaoying Wang; Yihui Fan
Journal:  Cell Mol Immunol       Date:  2017-02-13       Impact factor: 11.530

2.  An effective and efficient method of transfecting primary human chondrocytes in suspension.

Authors:  Mohammad Shahidul Makki; Nahid Akhtar; Tariq M Haqqi
Journal:  Anal Biochem       Date:  2017-03-14       Impact factor: 3.365

3.  Histone deacetylase inhibitor vorinostat (SAHA, MK0683) perturb miR-9-MCPIP1 axis to block IL-1β-induced IL-6 expression in human OA chondrocytes.

Authors:  Mohammad S Makki; Tariq M Haqqi
Journal:  Connect Tissue Res       Date:  2016-07-12       Impact factor: 3.417

Review 4.  The Role of MicroRNAs and Their Targets in Osteoarthritis.

Authors:  Gregory R Sondag; Tariq M Haqqi
Journal:  Curr Rheumatol Rep       Date:  2016-08       Impact factor: 4.592

Review 5.  Epigenetics in osteoarthritis: Potential of HDAC inhibitors as therapeutics.

Authors:  Nazir M Khan; Tariq M Haqqi
Journal:  Pharmacol Res       Date:  2017-08-18       Impact factor: 7.658

6.  Combination of circulating miR-19b-3p, miR-122-5p and miR-486-5p expressions correlates with risk and disease severity of knee osteoarthritis.

Authors:  Ruina Kong; Jie Gao; Yanhui Si; Dongbao Zhao
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

7.  Histone Deacetylase Inhibitor Vorinostat (SAHA) Suppresses IL-1β-Induced Matrix Metallopeptidase-13 Expression by Inhibiting IL-6 in Osteoarthritis Chondrocyte.

Authors:  Mohammad Shahidul Makki; Tariq M Haqqi
Journal:  Am J Pathol       Date:  2016-08-20       Impact factor: 4.307

8.  Epigallocatechin-3-O-gallate modulates global microRNA expression in interleukin-1β-stimulated human osteoarthritis chondrocytes: potential role of EGCG on negative co-regulation of microRNA-140-3p and ADAMTS5.

Authors:  Zafar Rasheed; Naila Rasheed; Osama Al-Shaya
Journal:  Eur J Nutr       Date:  2017-01-21       Impact factor: 5.614

9.  Nrf2/ARE pathway attenuates oxidative and apoptotic response in human osteoarthritis chondrocytes by activating ERK1/2/ELK1-P70S6K-P90RSK signaling axis.

Authors:  Nazir M Khan; Imran Ahmad; Tariq M Haqqi
Journal:  Free Radic Biol Med       Date:  2018-01-12       Impact factor: 7.376

10.  MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression.

Authors:  Zhaozhou Ren; Ming He; Tao Shen; Kejia Wang; Qingjie Meng; Xiangxu Chen; Long Zhou; Yanshuo Han; Chao Ji; Shengnan Liu; Qin Fu
Journal:  Cancer Biol Ther       Date:  2019-11-12       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.